Yuanta Investment

RideFlux is a South Korean self-driving software company focused on safe and reliable autonomous transportation. The firm develops autonomous driving software and pilot services, including remote vehicle control and high-precision map operation, to enable safe, efficient mobility. Founded in 2018, RideFlux conducts development and testing in Jeju Island, leveraging its varied road environments and weather conditions to advance urban autonomy. The company aims to provide integrated software and services that support autonomous driving for consumer and mobility services, emphasizing safety and reliability in autonomous transportation.

The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective of developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease. In 2016, the company took significant steps toward formalizing its presence in the market by completing its incorporation and business registration processes. The year 2017 proved to be a milestone for the company as it obtained certification as a corporate-affiliated research institute, solidifying its position as a reputable research-driven organization. Additionally, it garnered recognition as a leading university start-up by the Ministry of SMEs and Startups, further boosting its credibility and potential for growth. The company has collaborated with Oscotech Co., Ltd. and partnered with various investors, including Kite Entrepreneurship Foundation, Stone Bridge Ventures Co., Ltd., Korea Development Bank, and Stick Ventures Co., Ltd., to jointly develop their projects.

The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

Kukka, Inc. is a Seoul-based company that specializes in providing a variety of flower-related services, including flower subscription, bouquet delivery, and custom floral design. Established in 2014, Kukka aims to promote the enjoyment of flowers in everyday life, inspired by Finnish culture. Its offerings cater to both individual and corporate clients, featuring corporate event support flowers, promotional flower boxes, and floral decorations. The company also provides same-day delivery and organizes flower art classes, enhancing the floral experience for its customers. Through its retail stores and online platform, Kukka facilitates easy access to fresh flowers and related accessories.

Dealicious operates as an online marketplace designed to connect fashion wholesalers and retailers on a global scale. By facilitating direct access to a vast selection of quality merchandise, including clothing, bags, shoes, and accessories, Dealicious streamlines the wholesale purchasing process. The platform primarily focuses on the Dongdaemun fashion district in South Korea, renowned for its concentration of fashion manufacturing and distribution within a compact area. With approximately 11,000 registered wholesale stores, Dealicious enables retailers to browse and order from a diverse array of items, with 24,000 new products added daily. This approach eliminates the need for retailers to visit physical markets, allowing them to save valuable time and resources. Dealicious is committed to enhancing the user experience by continuously developing customer-centric services that ensure seamless access to high-quality products in the Korean fashion market.

3billion is a Seoul-based company that provides genetic testing and analysis services for rare disease patients. Founded in 2016, it uses bioinformatics and machine learning to shorten and reduce the cost of genome interpretation, aiming to make genome-scale testing accessible for patients in need. The company develops AI-driven diagnostic tools and offers products such as 3B-GENOME, 3B-EXOME, 3B-VARIANT, and 3B-INTERPRETER to support comprehensive genetic analysis and faster diagnosis.

SolarConnect, Inc. is a South Korean company that specializes in the production of solar energy and provides information technology-based energy solutions. Established in 2016 and headquartered in Seoul, the company operates solar energy plants and installs solar panels in residential areas and apartments. SolarConnect aims to integrate innovative financial and technological solutions into the solar and energy industries, contributing to the advancement of sustainable energy practices.

Shaperon is a clinical-stage biotechnology company specializing in the research and development of immunological cells and inflammasome inhibitors. Founded in 2008, it is headquartered in Seoul, South Korea.

Lmito Therapeutics Inc. is a clinical-stage biotechnology company based in Seongnam-si, South Korea, founded in 2017. The company focuses on modulating cell metabolism to create innovative immunotherapeutic compounds in the fields of immunology, neuro-immunology, and immuno-oncology. Lmito specializes in the discovery of mitochondrial drugs aimed at addressing metabolic syndromes, age-related neurodegenerative diseases, and mitochondrial respiratory chain disorders. It develops treatments that regulate the metabolism of brain immune cells and targets auto-inflammatory and autoimmune diseases. Through its research and development efforts, Lmito Therapeutics aims to provide effective therapies for various neurological and immune-related disorders.

Cardoc Inc. is a South Korean company founded in 2013 that specializes in automotive repair services through a mobile application. The app allows users to upload photographs of their vehicle's exterior damage, facilitating real-time quotations, consultations, and repair options from selected car body shops. Users can receive their first estimate within an average of seven minutes and compare multiple estimates without the need to register personal information. Cardoc has demonstrated significant growth, with registered stores experiencing monthly increases of 30-100%. The company also offers additional vehicle management services, including car inspections, washes, and renewal services, which can be reserved online or at car centers. The founding team comprises automotive enthusiasts who have benefited from support from a startup incubation organization.

The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

Founded in Seoul, South Korea in 2010, Zigbang operates a property listing platform and application that connects real estate agents with renters. It offers an apartment hunting service, enabling users to search for rental properties based on criteria such as number of rooms, occupants, and price.

Bionoxx is a biotechnology company based in Seongnam-si, South Korea, focused on developing innovative cancer immunotherapy treatments. The company specializes in oncolytic virus therapies, particularly utilizing vaccinia viruses armed with transgenes to enhance safety and efficacy. Bionoxx's portfolio includes OTS-412 and mOTS-412, which are oncolytic viruses designed for cancer treatment. Additionally, the company develops universal tumor targeting antigen (UTTA) technologies, such as UTTA CAR-T and UTTA BsAb, aimed at eradicating solid tumors. Bionoxx also explores combination therapies like mOTS-412+ ICI to enhance immune responses against cancer.